5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide

C26H27F2N9O2 — CID 135356068

IUPAC5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide
SMILESCN1CC[C@H](NC(=O)c2nnc(C3CC(F)(F)C3)o2)c2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C1
InChIInChI=1S/C26H27F2N9O2/c1-36-8-6-21(32-22(38)24-35-34-23(39-24)17-10-26(27,28)11-17)19-4-3-15(9-16(19)13-36)20-5-7-29-25(33-20)31-18-12-30-37(2)14-18/h3-5,7,9,12,14,17,21H,6,8,10-11,13H2,1-2H3,(H,32,38)(H,29,31,33)/t21-/m0/s1
InChIKeyWZJYUDVCZSTXEW-NRFANRHFSA-N
MW535.56 g/mol
LogP3.82
Rot. Bonds6

About 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide

5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide (PubChem CID 135356068) has the molecular formula C26H27F2N9O2 and a molecular weight of 535.56 g/mol. Its IUPAC name is 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide.

Molecular Properties

Compound Name5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide
PubChem CID135356068
Molecular FormulaC26H27F2N9O2
Molecular Weight535.56 g/mol
Exact Mass535.23
IUPAC Name5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide
SMILESCN1CC[C@H](NC(=O)c2nnc(C3CC(F)(F)C3)o2)c2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C1
InChIInChI=1S/C26H27F2N9O2/c1-36-8-6-21(32-22(38)24-35-34-23(39-24)17-10-26(27,28)11-17)19-4-3-15(9-16(19)13-36)20-5-7-29-25(33-20)31-18-12-30-37(2)14-18/h3-5,7,9,12,14,17,21H,6,8,10-11,13H2,1-2H3,(H,32,38)(H,29,31,33)/t21-/m0/s1
InChIKeyWZJYUDVCZSTXEW-NRFANRHFSA-N
XLogP3.82
TPSA126.89 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds6
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500535.56
LogP ≤ 53.82
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide?
The IUPAC name of 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide (CID 135356068) is 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide.
What is the SMILES notation for 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide?
The canonical SMILES for 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide is CN1CC[C@H](NC(=O)c2nnc(C3CC(F)(F)C3)o2)c2ccc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C1.
What is the InChIKey of 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide?
The InChIKey is WZJYUDVCZSTXEW-NRFANRHFSA-N. The full InChI is InChI=1S/C26H27F2N9O2/c1-36-8-6-21(32-22(38)24-35-34-23(39-24)17-10-26(27,28)11-17)19-4-3-15(9-16(19)13-36)20-5-7-29-25(33-20)31-18-12-30-37(2)14-18/h3-5,7,9,12,14,17,21H,6,8,10-11,13H2,1-2H3,(H,32,38)(H,29,31,33)/t21-/m0/s1.
What are the key properties of 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide?
5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide has a molecular weight of 535.56 g/mol, XLogP of 3.82, 6 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(3,3-difluorocyclobutyl)-N-[(5S)-2-methyl-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide is sourced from PubChem (CID 135356068), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).